Reports for BAYER INC
Company Name
BAYER INC
Totals |
||
Shortage reports |
85 |
|
| Actual shortage: | 8 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (12%) | |
| Resolved: | 67 (79%) | |
Discontinuation Reports |
23 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 22 (96%) | |
| Reversed: | 1 (4%) | |
Late reports |
6 (6%) |
|
Overdue reports |
1 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-27 | 2022-11-23 | 172777 |
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Resolved | 2023-03-29 | 2023-06-05 | 188217 |
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Resolved | 2024-01-11 | 2024-02-06 | 215608 |
| XARELTO | 103.4MG | GRANULES FOR SUSPENSION | Resolved | 2022-08-24 | 2022-10-29 | 167663 |
| XARELTO | 103.4MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-29 | 2023-11-17 | 196862 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GLUCOBAY | 50MG | TABLET | Discontinued | 2023-07-11 | 2023-07-11 | 198131 |
| STAXYN | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-07-14 | 2023-07-14 | 198701 |
| STAXYN | 10MG | TABLET (ORALLY DISINTEGRATING) | Reversed | 2022-06-20 | 2022-09-19 | 163103 |